News - Appointments

Christopher Vann becomes COO at Autolus

Christopher Vann

Christopher Vann has been named chief operating officer of Autolus Ltd, a portfolio company of the Syncona investment group which is developing engineered T cell immu

Country: United Kingdom

Read more

Freeline appoints Anne Prener as CEO

Anne Prener

Anne Prener, an experienced haematology executive, has been appointed chief executive officer of Freeline Therapeutics Ltd, which is developing a gene therapy for ble

Country: United Kingdom

Read more

Melissa Yeager leads regulatory affairs at Breath Therapeutics

Melissa Yeager

Breath Therapeutics BV has appointed Melissa Yeager to the newly created position of chief regulatory officer to prepare for the commercialisation of its inhalation t

Country: Germany

Read more

Steve Swinson becomes chairman of Bone Therapeutics

Steve Swinson

Steve Swinson has been elected chairman of the board of Bone Therapeutics SA of Belgium, replacing Michel Helbig, who will continue as a non-executive director.

Country: Belgium

Read more

Paul Stockdale to become CFO at Oxford BioDynamics

Paul Stockdale

Paul Stockdale has been appointed chief financial officer at Oxford BioDynamics Plc, effective 15 September.

Country: United Kingdom

Read more

Mohamed Ragab joins iTeos Therapeutics

Mohamed Ragab

Mohamed Ragab has been appointed vice president of corporate development at iTeos Therapeutics SA which is developing immunotherapies for cancer.

Country: Belgium

Read more

Steve Jackson to chair advisory board at Mission Therapeutics

Steve Jackson

Steve Jackson, a pioneer in the field of DNA repair, is to chair a new scientific advisory board at Mission Therapeutics Ltd, a company that is targeting deubiquityla

Country: United Kingdom

Read more

Sally Waterman becomes COO at Medherant

Sally Waterman

Sally Waterman has joined Medherant Ltd as chief operating officer as the Warwick University spin-out prepares for the clinical development and commercialisation of i

Country: United Kingdom

Read more

Jean-Charles Soria joins Innate Pharma supervisory board

Jean-Charles Soria

Jean-Charles Soria, a medical oncologist and researcher, has joined the supervisory board of Innate Pharma SA to help the French company advance its portfolio of ther

Country: France

Read more

Chris Posner to head LEO Pharma’s US business

Chris Posner

The Danish dermatology company LEO Pharma A/S has appointed Chris Posner as head of its US operations to lead an expansion of the company’s business.

Country: Denmark

Read more